SAFETY AND IMMUNOGENICITY OF CORONAVAC AND CHADOX1 VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTRIC STUDY

Cruz, V; Machado, KLLL; da Silva, VG; Tapia, KRL; Ferreira, LB; Burian, APN; Dias, LH; Gadelha, CSE; de Oliveira, YGP; de Lima, MD; Pasti, LP; de Oliveira, JR; Albertino, LF; Macabu, MD; Lorencini, PZ; Magalhaes, VD; De Aguiar, MF; Biegelmeyer, E; Ribeiro, PDC; Peixoto, FMMMC; Kayser, C; de Souza, AWS; Castro, CHD; Ribeiro, SLE; Sanches, RHD; Boechat, AL; Takatani, VMP; Yasuda, CR; Rego, DQ; Alagia, RBN; Rebello, RT; Bühring, J; Sartori, NS; de Andrade, NPB; Gasparini, ML; de Melo, AKG; Melo, TS; Rego, J; Vieira, RMRD; Vieira, ASR; Tavares, ACFMG; Kakehasi, AM; de Landa, ATDT; Corrêa, MCD; Azevedo, VF; Martins, OA; Peruhype-Magalhaes, V; Pinheiro, MD; Monticielo, OA; Neto, ETD; Ferreira, GA; de Souza, VA; Teixeira-Carvalho, A; Xavier, RM; Sato, EI; Valim, V; Pileggi, GS; Silva, NAD

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023; 29 (): S7